BlueWind Medical wins FDA nod for tibial neuromod implant
BlueWind Medical announced today that the FDA granted a de novo marketing request for its Revi neuromodulation system.
Royt Parker Dan Lemaitre Cindyl Amundsen Division Of Urogynecology Urology At Duke University School Of Medicine Park City
Source: massdevice.com